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Abstract
Many autoimmune diseases share similar underlying pathology and have a tendency to cluster
within families, giving rise to the concept of shared susceptibility genes among them. In the Genetic
Analysis Workshop 16 rheumatoid arthritis (RA) data we sought to replicate the genetic
association between single-nucleotide polymorphisms (SNPs) identified in recent genome-wide
association studies (GWAS) on RA and five other autoimmune diseases. We identified 164
significantly associated non-HLA SNPs (p <1 0
-5) from 16 GWAS and 13 candidate gene studies on
six different autoimmune diseases, including RA, systemic lupus erythematosus, type 1 diabetes,
Crohn disease, multiple sclerosis, and celiac disease. Using both direct and imputation-based
association test, we replicated 16 shared susceptibility regions involving RA and at least one of the
other autoimmune diseases. We also identified hidden population structure within cases and
controls in Genetic Analysis Workshop 16 RA data and assessed the effect of population structure
on the shared autoimmunity regions. Because multiple autoimmune diseases share common genetic
origin, these could be areas of immense interest for further genetic and clinical association studies.
Background
Autoimmune diseases affect 5% of the human popula-
tion [1]. Although there is considerable heterogeneity
among these disorders, their manifestations are believed
to arise from immune-mediated attack against self-
antigens. Despite their clinical heterogeneity, recent
studies examining gene expression profiles in peripheral
blood mononuclear cells (PBMC) of individuals with
autoimmune disorders reveal common features that are
either shared within a disease group or among disease
groups as exemplified in rheumatoid arthritis (RA) [2] or
in systemic lupus erythematosus (SLE) [3]. The major
symptoms of RA arise through immune-mediated
destruction of peripheral joints; however, these features
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such as rheumatoid nodules and vasculitis. Immune-
mediated destruction is the central feature of autoim-
mune diseases like SLE, type 1 diabetes (T1D), multiple
sclerosis (MS), and celiac disease (CLD). Given the
similarities in the basic pathology of these autoimmune
disorders, it is not surprising to see autoimmune diseases
clustering within families, which leads to the hypothesis
of common autoimmunity genes being shared between
diseases. An example of such shared gene is Runx1,
which is shown to be associated with SLE, psoriasis, and
RA [4]. Increasing numbers of GWAS for autoimmune
disorders have enhanced the possibility of identifying
such shared autoimmune regions.
The goals of the present study are 1) to identify
population structure in Genetic Analysis Workshop
(GAW) 16 RA cases and controls, 2) to replicate the
genetic association in RA identified from recent GWAS
on six common autoimmune diseases [RA, Crohn
disease (CD), CLD, SLE, MS, and T1D], and 3) to
study the effect of admixture on associated regions.
Methods
After searching the PubMed database we identified
recently published 16 GWAS and other 13 candidate
gene association studies [5-28] on RA, CD, SLE, MS,
CLD, and T1D. SNPs which showed significant associa-
tion at a genome-wide “suggestive” threshold (p <1 0
-5)
were chosen for replication in GAW16 RA data. The
preselected threshold (p <1 0
-5) was chosen as “sugges-
tive” to control properly the family-wide type 1 error as
recommended by Duggal et al. [29] to adjust p-value to
control the family-wide type 1 error in genome-wide
association studies. The rationale for choosing this
threshold was to maximize true associations from the
GWAS. We performed an association analysis using
predefined quality control criteria (MAF ≥ 1%, SNP
missingness rate of ≤ 10%, and Hardy-Weinberg equili-
brium ≥ 0.001 in controls) and identified significant
S N P sf o rR Ae i t h e rb yd i r e c ta s s o c i a t i o nu s i n gP L I N K
[30] or by imputation using fastPHASE [31].
To identify the hidden population structure in cases and
controls, we estimated and compared the likelihood of
this data under different numbers of ancestral popula-
tions (k). We used STRUCTURE [32] for estimating the
best k separately for cases and controls. We identified
343 ancestry informative markers (AIMs) from two
previously published reports [33,34] that were available
in GAW16 RA data. These AIMs were used in both
estimating population structure and admixture propor-
tion in each individual, as well as correcting for the effect
of population substructure in genetic association. We
employed two different methods for controlling the
effect of population substructure, i.e., structured associa-
tion test (SAT) [35] with 10,000 permutations and
covariate-adjusted logistic regression. We also included
sex as a covariate in the logistic regression model;
however, it did not significantly affect the association
results and was excluded from the final model. To
corroborate the evidence of population structure we
performed principal-component analysis using EIGEN-
SOFT. We evaluated the statistical significance of each
eigenvector using Tracy-Widom (TW) statistics as
described by Patterson et al. and calculated the total
variation explained by the significant eigenvector [36].
Finally, we sought to replicate regions that showed
association signals across GAW16 data and at least one
of the GWAS. If the associated SNPs were not present
(either failed or were not genotyped in the study) in the
GAW16 data, we looked at the surrounding region in the
GAW data (100-kb region centered on the published
associated SNP). If any of the SNPs from these regions
showed significance at a replication threshold of
p < 0.05, we imputed this region using HAPMAP data
(60 unrelated CEU parents) and assessed association.
Results
We have identified substantial population substructure
in GAW16 RA samples. Figure 1A and 1B show estimated
structured likelihood probability of data for cases and
controls, respectively. The best fitted model for cases
favored the assumption of a two-population model
(ancestry proportion = 0.955, 0.045) and three-popula-
tion model for controls (ancestry proportion = 0.771,
0.115, 0.074). However, a combined case-control data
favored a three-population model (ancestry proportion =
0.528, 0.257, 0.215). For controls, the likelihood
probabilities for two-, three-, and four-population
models are similar and that for cases, the likelihood
probabilities for a two- and three-population model is
similar. We ran principal-components analysis on the
combined cases-control data and calculated TW statistics
[36] for the top 10 eigenvectors, and 4 significant
eigenvectors (p > 0.05) explained 23% of the variation
in the whole dataset. This suggests substantial popula-
tion structure within GAW16 data.
We initially selected 164 non-HLA associated SNPs from
16 recently published GWAS and 13 candidate gene
association studies (p <1 0
-5) to check for replication in
the GAW16 dataset. We found associated SNPs for SLE
(n = 49), CD (n = 39), T1D (n = 32), RA (n =3 7 ) ,C L D
(n =4 ) ,a n dM S( n = 9). Of these 164 SNPs, 92 SNPs
were found in the GAW16 data and evaluated by a direct
allelic association test. The remaining 72 SNPs were
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these 164 SNPs, 29 were significantly replicated (p <
0.05). Nine of these SNPs replicated at p-values between
0.05 and 0.01, 11 were between 0.01 and 10
-5,a n d8
replicated at p <1 0
-5. Table 1 shows susceptibility loci
with the p-values for autoimmune diseases (CD, CLD,
T1D, SLE, and RA) identified from various GWAS. The
last two columns show association based p-values for the
same loci in the entire GAW16 RA data and p-values
adjusted for population admixture.
Discussion
There is a growing understanding that susceptibility to
autoimmune diseases is due to a complex interaction of
multiple genes and environmental factors, and many of
these may be shared among many autoimmune diseases.
In this analysis we attempted to replicate previously
identified associations in multiple autoimmune diseases
and inferred regions of shared autoimmunity between
GAW16 data and any other autoimmune disease. We did
not explore the HLA region in our study because this
region has already been extensively investigated and is a
very well know complex region of shared autoimmunity
among various autoimmune disorders [37,38].
GWAS have emerged as an effective tool to identify
common polymorphism underlying complex diseases.
One of the major sources of bias in GWAS is population
stratification, a variation of ancestry proportions
between cases and controls. This stratification can lead
to differences in allele frequency between cases and
controls unrelated to disease status, consecutively lead-
ing to an increased type 1 error [9]. We used 343 AIMs
and applied them to cases and controls separately to
infer population structure. We have demonstrated
substantial population substructure in both cases and
controls. In fact, we have identified more sub-structure in
controls than cases. Obviously, this would have major
impact if not corrected properly while performing
association studies.
We identified 16 different cytogenetic regions of shared
autoimmunity between GAW16 data and at least one of
the proposed autoimmune diseases. There were eight
shared regions with SLE (1p13, 2q32.2-q32.3, 6p21.32,
6q23, 8p21.3, 8p23.1, 22q11.21, 22q13.2), six shared
regions with CD (1p31, 3p21, 5p13, 6q27, 10q24, 19q13),
four shared regions with RA (1p13, 2q32.2-q32.3, 4q27,
9q33.2), four shared regions with T1D (1p13, 2q24, 2q33,
4q27), and one shared region with CLD (4q27). Interest-
ingly, PTPN22 (1p13), STAT4 (2q32.2-q32.3), and
KIAA1109 (4q27) were all associated with multiple
autoimmune disease. It should also be noted that SLE
shared the most susceptibility genes with RA, suggesting
common underlying pathologic processes perpetrated by
common loci. These associations are constant, robust, and
persisted after correcting for population structure. It is also
noteworthy to report that none of the nine associated SNPs
from MS are replicated in the GAW16 RA data.
However, our study was not an exhaustive replication with
RA and the five other autoimmune diseases because SNPs
were chosen using a predefined threshold (p <1 0
-5). It is
possible that SNPs that showed weak to moderate
association (0.05-10
-5) with other autoimmune disease
could have been highly associated with RA. Also, the other
studies from which the list of 164 non-HLA SNPs were
selected do not all control for population admixture so it is
possible that we missed analyzing an important SNP in the
GAW16 data. We did not evaluate that possibility. It is
worth future research to look more exhaustively at SNPs
Figure 1
Likelihood of data under number of hidden populations (K) estimated separately for controls (A) and cases (B).
K denotes number of populations.
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pass genome-wide significance but are significant at the
p < 0.05 level.
Conclusion
It has long been suspected that autoimmune diseases
may share common pathogenesis and susceptibility
genes, and several recent studies [4,5] support this
hypothesis. Identification of these shared regions can
help in identification of novel genetic pathways in
autoimmune disease causation, can increase under-
standing higher prevalence of different autoimmune
disorders in families, and may identify targeted regions
for gene therapy. Our study successfully identified 16
areas of shared susceptibility involving RA and other
autoimmune diseases. These can be further explored by
association and clinical studies to solve the conundrum
of shared autoimmunity amongst various autoimmune
diseases.
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1 1p31 IL23R rs11465804 67414547 CD 1.09 × 10
-3 1.04 × 10
-3 2.04 × 10
-3
1 1p13 PTPN22 rs2476601 114089610 SLE, RA,
T1D
1.12 × 10
-12 1.76 × 10
-10 2.66 × 10
-10
2 2q24 IFIH1 rs1990760 162949558 T1D 6.54 × 10
-3 2.74 × 10
-2 2.44 × 10
-2
2 2q32.2-q32.3 STAT4 rs6752770 191681808 RA, SLE 7.00 × 10
-3 1.36 × 10
-2 3.36 × 10
-2
3 3p21 MST1 rs3197999 49696536 CD 2.31 × 10
-2 3.57 × 10
-2 3.57 × 10
-2
4 4q27 KIAA1109 rs13151961 123473107 Celiac T1D,
RA
4.81 × 10
-2 2.74 × 10
-2 3.74 × 10
-2
5 5p13 PTGER4 rs4613763 40428485 CD 1.96 × 10
-3 7.56 × 10
-3 5.56 × 10
-3
6 6q23 near TNFAIP3 rs6933404 138000928 SLE 3.13 × 10
-4 2.01 × 10
-3 3.01 × 10
-3
6 6q23 near TNFAIP3 rs13192841 138008907 SLE 2.93 × 10
-4 5.71 × 10
-4 6.47 × 10
-4
6 6q23 near TNFAIP3 rs12527282 138008945 SLE 2.28 × 10
-4 3.37 × 10
-4 2.27 × 10
-4
6 6q23 near TNFAIP3 rs2327832 138014761 SLE 1.06 × 10
-4 7.51 × 10
-4 6.51 × 10
-4
6 6q23 near TNFAIP3 rs602414 138053358 SLE 6.03 × 10
-4 1.29 × 10
-2 1.29 × 10
-2
6 6q27 CCR6 rs2301436 167408399 CD 1.67 × 10
-2 1.74 × 10
-2 4.25 × 10
-2
8 8p23.1 XKR6 rs11783247 10826285 SLE 4.50 × 10
-2 1.76 × 10
-2 5.77 × 10
-2
8 8p21.1 C8orf12 rs7836059 11309574 SLE 8.87 × 10
-3 1.36 × 10
-2 6.78 × 10
-2
8 8p21.3 C8orf13-BLK rs2736340 11381382 SLE 1.45 × 10
-5 2.38 × 10
-5 0
8 8p21.3 C8orf13-BLK rs13277113 11386595 SLE 3.46 × 10
-6 5.69 × 10
-6 0
8 8p23.1 BLK rs2618476 11389950 SLE 3.21 × 10
-6 4.10 × 10
-6 *
c
8 8p23.1 BLK rs2248932 11429059 SLE 9.79 × 10
-3 6.49 × 10
-3 6.69 × 10
-3
9 9q33.2 PHF19 rs1953126 122680321 RA 2.76 × 10
-8 4.97 × 10
-8 0
9 9q33.2 PHF19 rs1609810 122682172 RA 1.79 × 10
-8 3.38 × 10
-8 *
9 9q33.2 PHF19 rs881375 122692719 RA 2.27 × 10
-8 4.55 × 10
-8 0
9 9q33.2 PHF19 rs6478486 122695150 RA 1.79 × 10
-8 3.38 × 10
-8 *
9 9q33.2 near PHF19 rs3761847 120769793 RA 1.24 × 10
-8 3.88 × 10
-8 0
9 9q33.2 C5 rs2900180 122776861 RA 6.24 × 10
-9 1.88 × 10
-8 0
10 10q24 NKX2-3 rs11190140 101281583 CD 4.93 × 10
-2 8.10 × 10
-2 8.80 × 10
-2
19 19q13 RSHL1 rs8111071 50999246 CD 5.91 × 10
-5 1.66 × 10
-4 0
22 22q11.21 UBE2L3 rs5754217 20264229 SLE 8.94 × 10
-3 6.34 × 10
-3 6.57 × 10
-3
22 22q13.2 SCUBE1 rs2071725 41934258 SLE 2.23 × 10
-2 1.83 × 10




c *, Imputed SNP.
BMC Proceedings 2009, 3(Suppl 7):S31 http://www.biomedcentral.com/1753-6561/3/S7/S31
P a g e4o f6
(page number not for citation purposes)Authors’ contributions
SKN conceived of the study, and participated in its
design and coordination and helped to draft the manu-
script. HAD and XK-H did the analysis and drafted the
manuscript.
Acknowledgements
The genetic analysis workshops are supported by NIH grant R01
GM031575 from the National Institute of General Medical Sciences, and
R01 AI063622 from the National Institute of Allergy and Infectious
Diseases.
This article has been published as part of BMC Proceedings Volume 3
Supplement 7, 2009: Genetic Analysis Workshop 16. The full contents of
the supplement are available online at http://www.biomedcentral.com/
1753-6561/3?issue=S7.
References
1. Marrack P, Kappler J and Kotzin BL: Autoimmune disease: why
and where it occurs. Nat Med 2001, 7:899–905.
2. Olsen N, Sokka T, Seehorn CL, Kraft B, Maas K, Moore J and
Aune TM: A gene expression signature for recent onset
rheumatoid arthritis in peripheral blood mononuclear cells.
Ann Rheum Dis 2004, 63:1387–1392.
3 . B e n n e t tL ,P a l u c k aA K ,A r c eE ,C a n t r e l lV ,B o r v a kJ ,B a n c h e r e a uJ
and Pascual V: Interferon and granulopoiesis signatures in
systemic lupus erythematosus blood. JE x pM e d2003,
197:711–723.
4. Alarcón-Riquelme ME: A RUNX trio with a taste for auto-
immunity. Nat Genet 2003, 35:299–300.
5. Wellcome Trust Case Control Consortium: Genome-wide
association study of 14,000 cases of seven common diseases
and 3,000 shared controls. Nature 2007, 447:661–678.
6. Chang M, Rowland CM, Garcia VE, Schrodi SJ, Catanese JJ, Helm-van
Mil van der AH, Ardlie KG, Amos CI, Criswell LA, Kastner DL,
Gregersen PK, Kurreeman FA, Toes RE, Huizinga TW, Seldin MF and
Begovich AB: A large-scale rheumatoid arthritis genetic study
identifies association at chromosome 9q33.2. PLoS Genet 2008,
4:e1000107.
7. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW,
de Bakker PI, Le JM, Lee HS, Batliwalla F, Li W, Masters SL,
Booty MG, Carulli JP, Padyukov L, Alfredsson L, Klareskog L,
Chen WV, Amos CI, Criswell LA, Seldin MF, Kastner DL and
Gregersen PK: STAT4 and the risk of rheumatoid arthritis
and systemic lupus erythematosus. NE n g lJM e d2007,
357:977–986.
8. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S,
Lee AT, Chung SA, Ferreira RC, Pant PV, Ballinger DG, Kosoy R,
Demirci FY, Kamboh MI, Kao AH, Tian C, Gunnarsson I,
Bengtsson AA, Rantapää-Dahlqvist S, Petri M, Manzi S, Seldin MF,
Rönnblom L, Syvänen AC, Criswell LA, Gregersen PK and
Behrens TW: Association of systemic lupus erythematosus
with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008,
358:900–909.
9. Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM,
Burtt NP, Guiducci C, Parkin M, Gates C, Plenge RM, Behrens TW,
Wither JE, Rioux JD, Fortin PR, Graham DC, Wong AK, Vyse TJ,
Daly MJ, Altshuler D, Moser KL and Gaffney PM: Genetic variants
near TNFAIP3 on 6q23 are associated with systemic lupus
erythematosus. Nat Genet 2008, 40:1059–1061.
10. Musone SL, Taylor KE, Lu TT, Nititham J, Ferreira RC, Ortmann W,
Shifrin N, Petri MA, Kamboh MI, Manzi S, Seldin MF, Gregersen PK,
Behrens TW, Ma A, Kwok PY and Criswell LA: Multiple
polymorphisms in the TNFAIP3 region are independently
associated with systemic lupus erythematosus. Nat Genet
2008, 40:1062–1064.
11. International Consortium for Systemic Lupus Erythematosus Genet-
ics (SLEGEN), Harley JB, Alarcón-Riquelme ME, Criswell LA,
Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ,
L a n g e f e l dC D ,N a t hS K ,G u t h r i d g eJ M ,C o b bB L ,M i r e lD B ,
Marion MC, Williams AH, Divers J, Wang W, Frank SG,
Namjou B, Gabriel SB, Lee AT, Gregersen PK, Behrens TW,
Taylor KE, Fernando M, Zidovetzki R, Gaffney PM, Edberg JC,
Rioux JD, Ojwang JO, James JA, Merrill JT, Gilkeson GS, Seldin MF,
Yin H, Baechler EC, Li QZ, Wakeland EK, Bruner GR, Kaufman KM
and Kelly JA: Genome-wide association scan in women with
systemic lupus erythematosus identifies susceptibility var-
iants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet
2008, 40:204–210.
12. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD,
Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A,
Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO,
Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH,
Targan SR, Xavier RJ, NIDDK IBD Genetics Consortium, Libioulle C,
Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D,
Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D,
Hugot JP, de Vos M, Vermeire S, Louis E, Belgian-French IBD
Consortium; Wellcome Trust Case Control Consortium,
Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T,
Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S,
Gwilliam R, Tremelling M, Deloukas P, Mansfield J, Jewell D,
Satsangi J, Mathew CG, Parkes M, Georges M and Daly MJ:
Genome-wide association defines more than 30 distinct
susceptibility loci for Crohn’sd i s e a s e .Nat Genet 2008,
40:955–962.
13. van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A,
Inouye M, Wapenaar MC, Barnardo MC, Bethel G, Holmes GK,
Feighery C, Jewell D, Kelleher D, Kumar P, Travis S, Walters JR,
Sanders DS, Howdle P, Swift J, Playford RJ, McLaren WM, Mearin ML,
Mulder CJ, McManus R, McGinnis R, Cardon LR, Deloukas P and
Wijmenga C: A genome-wide association study for celiac
disease identifies risk variants in the region harboring IL2
and IL21. Nat Genet 2007, 39:827–829.
14. International Multiple Sclerosis Genetics Consortium, Hafler DA,
Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de
Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA,
Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B,
Oksenberg JR and Hauser SL: Risk alleles for multiple sclerosis
identified by a genomewide study. NE n g lJM e d2007,
357:851–862.
15. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A,
Caillier SJ, Ban M, Goris A, Barcellos LF, Lincoln R, McCauley JL,
Sawcer SJ, Compston DA, Dubois B, Hauser SL, Garcia-Blanco MA,
Pericak-Vance MA, Haines JL and Multiple Sclerosis Genetics Group:
Interleukin 7 receptor alpha chain (IL7R) shows allelic and
functional association with multiple sclerosis. Nat Genet 2007,
39:1083–1091.
16. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E,
K h a d e m iM ,O t u r a iA ,R y d e rL P ,S a a r e l aJ ,H a r b oH F ,C e l i u sE G ,
Salter H, Olsson T and Hillert J: Variation in interleukin 7
receptor alpha chain (IL7R) influences risk of multiple
sclerosis. Nat Genet 2007, 39:1108–1113.
17. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V,
Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS,
Hafler JP, Zeitels L, Yang JH, Vella A, Nutland S, Stevens HE,
Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ,
Healy B, Burren OS, Lam AA, Ovington NR, Allen J, Adlem E,
Leung HT, Wallace C, Howson JM, Guja C, Ionescu-Tîrgovişte C,
Genetics of Type 1 Diabetes in Finland, Simmonds MJ, Heward JM,
Gough SC, Wellcome Trust Case Control Consortium, Dunger DB,
Wicker LS and Clayton DG: Robust associations of four new
chromosome regions from genome-wide analyses of type 1
diabetes. Nat Genet 2007, 39:857–864.
18. Helgason A, Pálsson S, Thorleifsson G, Grant SF, Emilsson V,
Gunnarsdottir S, Adeyemo A, Chen Y, Chen G, Reynisdottir I,
Benediktsson R, Hinney A, Hansen T, Andersen G, Borch-Johnsen K,
Jorgensen T, Schäfer H, Faruque M, Doumatey A, Zhou J,
Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C,
Sigurdsson G, Hebebrand J, Pedersen O, Thorsteinsdottir U,
Gulcher JR, Kong A, Rotimi C and Stefánsson K: Refining the
impact of TCF7L2 gene variants on type 2 diabetes and
adaptive evolution. Nat Genet 2007, 39:218–225.
19. Zhernakova A, Alizadeh BZ, Bevova M, van Leeuwen MA,
Coenen MJ, Franke B, Franke L, Posthumus MD, van Heel DA,
Steege van der G, Radstake TR, Barrera P, Roep BO, Koeleman BP
and Wijmenga C: Novel association in chromosome 4q27
region with rheumatoid arthritis and confirmation of type 1
diabetes point to a general risk locus for autoimmune
diseases. Am J Hum Genet 2007, 81:1284–1288.
20. Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, Allen JE,
Downes K, Barrett JC, Healy BC, Mychaleckyj JC, Warram JH and
Todd JA: Meta-analysis of genome-wide association study
BMC Proceedings 2009, 3(Suppl 7):S31 http://www.biomedcentral.com/1753-6561/3/S7/S31
P a g e5o f6
(page number not for citation purposes)data identifies additional type 1 diabetes risk loci. Nat Genet
2008, 40:1399–1401.
21. Grant SF, Qu HQ, Bradfield JP, Marchand L, Kim CE, Glessner JT,
Grabs R, Taback SP, Frackelton EC, Eckert AW, Annaiah K,
Lawson ML, Otieno FG, Santa E, Shaner JL, Smith RM, Skraban R,
Imielinski M, Chiavacci RM, Grundmeier RW, Stanley CA, Kirsch SE,
Waggott D, Paterson AD, Monos DS, DCCT/EDIC Research Group,
Polychronakos C and Hakonarson H: Follow-up analysis of
genome-wide association data identifies novel loci for type
1d i a b e t e s .Diabetes 2009, 58:290–295.
22. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S,
Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D,
Sina C, Onnie CM, Weersma RK, Stokkers PC, Wijmenga C,
G a z o u l iM ,S t r a c h a nD ,M c A r d l eW L ,V e r m e i r eS ,R u t g e e r t sP ,
Rosenstiel P, Krawczak M, Vatn MH, IBSEN Study Group,
Mathew CG and Schreiber S: Sequence variants in IL10,
ARPC2 and multiple other loci contribute to ulcerative
colitis susceptibility. Nat Genet 2008, 40:1319–1323.
23. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C,
Burtt NP, Gianniny L, Korman BD, Padyukov L, Kurreeman FA,
Chang M, Catanese JJ, Ding B, Wong S, Helm-van Mil van der AH,
Neale BM, Coblyn J, Cui J, Tak PP, Wolbink GJ, Crusius JB, Horst-
Bruinsma van der IE, Criswell LA, Amos CI, Seldin MF, Kastner DL,
Ardlie KG, Alfredsson L, Costenbader KH, Altshuler D,
Huizinga TW, Shadick NA, Weinblatt ME, de Vries N,
Worthington J, Seielstad M, Toes RE, Karlson EW, Begovich AB,
Klareskog L, Gregersen PK, Daly MJ and Plenge RM: Common
variants at CD40 and other loci confer risk of rheumatoid
arthritis. Nat Genet 2008, 40:1216–1223.
24. Julià A, Ballina J, Cañete JD, Balsa A, Tornero-Molina J, Naranjo A,
Alperi-López M, Erra A, Pascual-Salcedo D, Barceló P, Camps J and
Marsal S: Genome-wide association study of rheumatoid
arthritis in the Spanish population: KLF12 as a risk locus for
rheumatoid arthritis susceptibility. Arthritis Rheum 2008,
58:2275–2286.
2 5 . K o z y r e vS V ,A b e l s o nA K ,W o j c i kJ ,Z a g h l o o lA ,L i n g aR e d d yM P ,
Sanchez E, Gunnarsson I, Svenungsson E, Sturfelt G, Jönsen A,
Truedsson L, Pons-Estel BA, Witte T, D’Alfonso S, Barrizzone N,
Danieli MG, Gutierrez C, Suarez A, Junker P, Laustrup H, Francisca
González-Escribano M, Martin J, Abderrahim H and Alarcón-
Riquelme ME: Corrigendum: Functional variants in the B-
cell gene BANK1 are associated with systemic lupus
erythematosus. Nat Genet 2008, 40:484.
26. PlengeRM,SeielstadM,PadyukovL,LeeAT,RemmersEF,DingB,LiewA,
Khalili H, Chandrasekaran A, Davies LR, Li W, Tan AK, Bonnard C,
Ong RT, Thalamuthu A, Pettersson S, Liu C, Tian C, Chen WV, Carulli JP,
BeckmanEM,AltshulerD,AlfredssonL,CriswellLA,AmosCI,SeldinMF,
Kastner DL, Klareskog L and GregersenPK:TRAF1-C5 as a risk locus
for rheumatoid arthritis–a genomewide study. N Engl J Med 2007,
357:1199–1209.
27. Kuballa P, Huett A, Rioux JD, Daly MJ and Xavier RJ: Impaired
autophagy of an intracellular pathogen induced by a Crohn’s
disease associated ATG16L1 variant. PLoS ONE 2008, 3:e3391.
28. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, Franchimont D,
Vermeire S, Dewit O, de Vos M, Dixon A, Demarche B, Gut I,
Heath S, Foglio M, Liang L, Laukens D, Mni M, Zelenika D, Van
Gossum A, Rutgeerts P, Belaiche J, Lathrop M and Georges M:
Novel Crohn disease locus identified by genome-wide
association maps to a gene desert on 5p13.1 and modulates
expression of PTGER4. PLoS Genet 2007, 3:e58.
29. Duggal P, Gillanders EM, Holmes TN and Bailey-Wilson JE:
Establishing an adjusted p-value threshold to control the
family-wide type 1 error in genome wide association studies.
BMC Genomics 2008, 31:516.
30. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA,
Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ and Sham PC:
PLINK: a toolset for whole-genome association and popula-
tion-based linkage analysis. Am J Hum Genet 2007, 81:559–575.
31. FastPHASE. http://depts.washington.edu/ventures/UW_Technology/
Express_LicensesfastPHASE.php.
32. Pritchard JK, Stephens M and Donnelly P: Inference of population
structure using multilocus genotype data. Genetics 2000,
155:945–959.
33. Tian C, Plenge RM, Ransom M, Lee A, Villoslada P, Selmi C,
Klareskog L, Pulver AE, Qi L, Gregersen PK and Seldin MF: Analysis
and application of European genetic substructure using 300
K SNP information. PLoS Genet 2008, 4:e4.
34. Price AL, Butler J, Patterson N, Capelli C, Pascali VL, Scarnicci F,
Ruiz-Linares A, Groop L, Saetta AA, Korkolopoulou P, Seligsohn U,
Waliszewska A, Schirmer C, Ardlie K, Ramos A, Nemesh J,
Arbeitman L, Goldstein DB, Reich D and Hirschhorn JN: Discern-
ing the ancestry of European Americans in genetic associa-
tion studies. PLoS Genet 2008, 4:e236.
35. Pritchard JK, Stephens M, Rosenberg NA and Donnelly P: Associa-
tion mapping in structured populations. Am J Hum Genet 2000,
67:170–181.
36. Patterson N, Price AL and Reich D: Population structure and
eigenanalysis. PLoS Genet 2006, 2:e190.
37. Brand O, Gough S and Heward J: HLA, CTLA-4 and PTPN22:
the shared genetic master-key to autoimmunity?. Expert Rev
Mol Med 2005, 7:1–15.
38. Zanelli E, Breedveld FC and de Vries RR: HLA association with
autoimmune disease: a failure to protect?. Rheumatology
(Oxford) 2000, 39:1060–1066.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Proceedings 2009, 3(Suppl 7):S31 http://www.biomedcentral.com/1753-6561/3/S7/S31
P a g e6o f6
(page number not for citation purposes)